Manuscripts
Showing 1533 manuscripts.
Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life
Citation
Mark Mirochnick, Alice M. Stek, Midnela Acevedo, Margaret A. Keller, Diane Holland, Edmund Capparelli, James D. Connor, Sharon Huang, Michael Hughes, Lynne M. Mofenson, Yvonne J. Bryson. Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life. Journal of Acquired Immune Deficiency Syndromes. 2005. 39: 189-194.Year
2005
Journal
Journal of Acquired Immune Deficiency Syndromes
Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
Citation
John S. Lambert, Daniel Johnson, Elizabeth (Betsy) J. McFarland, Petronella Muresan, Terence Fenton, James McNamara, Jennifer S. Read, Elizabeth Hawkins, Pamela Bouquin, Scharla Estep, Georgia D. Tomaras, Carol A. Vincent, Mobeen H. Rathore, Ann J. Melvin, Sanjay Gurunathan. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.. Journal of Infectious Diseases. 2005. 192: 2129-2133.Year
2005
Journal
Journal of Infectious Diseases
Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.
Citation
John S. Lambert, John ( Jack ) Moye, Susan Plaeger, E. Richard Stiehm, James Bethel, Lynne M. Mofenson, Bonnie J. Mathieson, Jonathan Kagan, Howard Max Rosenblatt, Helene M.A. Paxton, Hildie Suter, Alan Landay. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.. Clinical and Diagnostic Laboratory Immunology. 2005. 12: 622-631.Year
2005
Journal
Clinical and Diagnostic Laboratory Immunology
Change in US research policies and directives are needed to remove barriers on HIV-1 operational research programs in developing countries: A case report of two NIH clinical trials in South Africa
Citation
Luis J. Montaner, James Alasdair McIntyre, Charles van der Horst, Ian M. Sanne. Change in US research policies and directives are needed to remove barriers on HIV-1 operational research programs in developing countries: A case report of two NIH clinical trials in South Africa. Harvard Health Policy Review. 2005. 6: 114-123.Year
2005
Journal
Harvard Health Policy Review
Transient viremia in HIV-infected patients and use of plasma preparation tubes
Citation
Valentina Stosor, Frank Palella, Baiba Berzins, Michelle Till, Angel Leake, Joan S. Chmiel, Robert L. Murphy. Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clinical Infectious Diseases. 2005. 14: 1671-4.Year
2005
Journal
Clinical Infectious Diseases
HIV type 1 genotypic variation in an antiretroviral treatement-naive population in Southern India
Citation
Pachamuthu (Bala) Balakrishnan, Nagalingeshwaran Kumarasamy, Rami Kantor, Suniti (Daralak) Solomon, Kenneth H. Mayer, David Katzenstein, Bharat Ramratnam. HIV type 1 genotypic variation in an antiretroviral treatement-naive population in Southern India. AIDS Research and Human Retroviruses. 2005. 21: 301-5.Year
2005
Journal
AIDS Research and Human Retroviruses
Drug resistance and antiretroviral drug development
Citation
Robert Shafer, Jonathan M. Schapiro. Drug resistance and antiretroviral drug development. Journal of Antimicrobial Chemotherapy. 2005. 55: 817-20.Year
2005
Journal
Journal of Antimicrobial Chemotherapy
Statistical methods for HIV dynamic studies in AIDS clinical trials
Citation
Hulin Wu. Statistical methods for HIV dynamic studies in AIDS clinical trials. Statistical Methods In Medical Research. 2005. 14: 171-92.Year
2005
Journal
Statistical Methods In Medical Research
Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy
Citation
Rupinderjeet J. Kaur, V. Klichko, David M. Margolis. Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy. AIDS Research and Human Retroviruses. 2005. 21: 116-24.Year
2005
Journal
AIDS Research and Human Retroviruses
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
Citation
Lynda Anne Szczech, Samir K. Gupta, Joseph A. Eustace, Jonathan A. Winston, Ivy I. Boydstun, Tejinder S. Ahuja, Rudolph Rodriguez, Karen T. Tashima, Michelle E. Roland, Nora Franceschini, Frank Palella, Jeffrey L. Lennox, Paul E. Klotman, Sharon Appelbaum Nachman, Stephen D Hall. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2005. 40: 1559-85.Year
2005
Journal
Clinical Infectious Diseases